Topic
Non-Muscle Invasive Bladder Cancer (NMIBC)
45 Podcasts • 4 Courses on BackTable
Hear how experienced physicians manage Non-Muscle Invasive Bladder Cancer (NMIBC) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 323 • 11 Aug 2026
Managing Intermediate-Risk Bladder Cancer
Recurrent low-grade, intermediate-risk bladder cancer presents a unique treatment challenge: recurrence is common, progression is uncommon, and the burden of repeated procedures can add up quickly. On this episode of the BackTable Urology Podcast, Dr. Ruchika Talwar interviews Dr. Charles "Chas" Peyton about how to manage intermediate-risk bladder cancer patients while balancing disease control and quality of life. They discuss the cumulative impact of repeated TURBTs and explore the evolving role of office-based treatments and chemoablative therapies as alternatives to the traditional treatment cycle.
More on Non-Muscle Invasive Bladder Cancer (NMIBC)
Loading recent podcasts…
Urology # 323
Aug 10, 2026
with Dr. Charles Peyton, Dr. Ruchika Talwar
Recurrent low-grade, intermediate-risk bladder cancer presents a unique treatment challenge: recurrence is common,...
1,400+ listens
Urology # 316
Jul 13, 2026
with Dr. Adam Gadzinski, Dr. Ruchika Talwar
As bladder cancer treatment options expand, so do the challenges of delivering them in real-world practice. On this...
Tumor Board # 69
Jun 24, 2026
with Meredith Donahue NP, Mary Dunn NP, Dr. Vignesh Packiam
How can clinics minimize toxicity and maximize outcomes in intravesical bladder cancer treatment? In this episode of...
Urology # 310
Jun 17, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
1,300+ listens
Urology # 320
Jul 30, 2026
with Dr. Sarah Psutka, Dr. Ruchika Talwar
Can a drug-eluting bladder device change the treatment algorithm for BCG-unresponsive non-muscle invasive bladder...
1,200+ listens
Urology # 312
Jun 24, 2026
with Meredith Donahue NP, Mary Dunn NP, Dr. Vignesh Packiam
How can clinics minimize toxicity and maximize outcomes in intravesical bladder cancer treatment? In this episode of...
1,000+ listens
Tumor Board # 67
Jun 17, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
Urology # 308
Jun 10, 2026
with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam
What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...
1,000+ listens
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.